Study of Grazoprevir (MK-5172) + Elbasvir (MK-8742) + Ribavirin in Participants With Chronic Hepatitis C Who Failed Prior Direct-Acting Antiviral Therapy (MK-5172-048)
Clinical trial NCT02105454 · COMPLETED
Trial details
- NCT number
- NCT02105454
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-23
- Primary completion
- 2015-05-04
- Enrollment
- 79
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.